Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC23627309;7310;7311 chr2:178774084;178774083;178774082chr2:179638811;179638810;179638809
N2AB23627309;7310;7311 chr2:178774084;178774083;178774082chr2:179638811;179638810;179638809
N2A23627309;7310;7311 chr2:178774084;178774083;178774082chr2:179638811;179638810;179638809
N2B23167171;7172;7173 chr2:178774084;178774083;178774082chr2:179638811;179638810;179638809
Novex-123167171;7172;7173 chr2:178774084;178774083;178774082chr2:179638811;179638810;179638809
Novex-223167171;7172;7173 chr2:178774084;178774083;178774082chr2:179638811;179638810;179638809
Novex-323627309;7310;7311 chr2:178774084;178774083;178774082chr2:179638811;179638810;179638809

Information

  • RefSeq wild type amino acid: L
  • RefSeq wild type transcript codon: CTT
  • RefSeq wild type template codon: GAA
  • Domain: Ig-13
  • Domain position: 7
  • Structural Position: 8
  • Q(SASA): 0.2034
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
L/F None None 1.0 D 0.717 0.637 0.831451841441 gnomAD-4.0.0 1.20032E-06 None None None None N None 0 0 None 0 0 None 0 0 1.3125E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
L/A 0.9363 likely_pathogenic 0.9295 pathogenic -1.698 Destabilizing 0.999 D 0.723 prob.delet. None None None None N
L/C 0.9479 likely_pathogenic 0.9369 pathogenic -1.468 Destabilizing 1.0 D 0.789 deleterious None None None None N
L/D 0.9986 likely_pathogenic 0.9983 pathogenic -0.604 Destabilizing 1.0 D 0.864 deleterious None None None None N
L/E 0.9933 likely_pathogenic 0.992 pathogenic -0.567 Destabilizing 1.0 D 0.869 deleterious None None None None N
L/F 0.8119 likely_pathogenic 0.7687 pathogenic -1.243 Destabilizing 1.0 D 0.717 prob.delet. D 0.670447136 None None N
L/G 0.9896 likely_pathogenic 0.9876 pathogenic -2.037 Highly Destabilizing 1.0 D 0.863 deleterious None None None None N
L/H 0.9868 likely_pathogenic 0.984 pathogenic -1.228 Destabilizing 1.0 D 0.851 deleterious D 0.727875347 None None N
L/I 0.25 likely_benign 0.2371 benign -0.83 Destabilizing 0.999 D 0.522 neutral D 0.591651532 None None N
L/K 0.9894 likely_pathogenic 0.9882 pathogenic -0.96 Destabilizing 1.0 D 0.849 deleterious None None None None N
L/M 0.3983 ambiguous 0.3714 ambiguous -0.878 Destabilizing 1.0 D 0.749 deleterious None None None None N
L/N 0.9867 likely_pathogenic 0.9844 pathogenic -0.85 Destabilizing 1.0 D 0.867 deleterious None None None None N
L/P 0.9307 likely_pathogenic 0.947 pathogenic -1.089 Destabilizing 1.0 D 0.869 deleterious D 0.548975028 None None N
L/Q 0.9756 likely_pathogenic 0.9711 pathogenic -0.972 Destabilizing 1.0 D 0.867 deleterious None None None None N
L/R 0.9826 likely_pathogenic 0.9795 pathogenic -0.523 Destabilizing 1.0 D 0.869 deleterious D 0.728802856 None None N
L/S 0.9876 likely_pathogenic 0.9852 pathogenic -1.637 Destabilizing 1.0 D 0.849 deleterious None None None None N
L/T 0.9412 likely_pathogenic 0.9317 pathogenic -1.467 Destabilizing 1.0 D 0.835 deleterious None None None None N
L/V 0.3618 ambiguous 0.3385 benign -1.089 Destabilizing 0.999 D 0.503 neutral D 0.671146127 None None N
L/W 0.982 likely_pathogenic 0.9751 pathogenic -1.239 Destabilizing 1.0 D 0.802 deleterious None None None None N
L/Y 0.9884 likely_pathogenic 0.9848 pathogenic -0.99 Destabilizing 1.0 D 0.855 deleterious None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.